Consequently, we hypothesise that the superior response of NRAS mutant melanoma to ICI and anti‐angiogenic combination treatment may be due to its more pronounced abnormal angiogenesis, making it more susceptible to anti‐angiogenic treatment. Here, NRAS is linked to melanoma.